Citation: A. Chiolero et al., Specific inhibitors of type 2 cyclooxygenase less renal effects than classical non steroidal anti-inflammatory agents?, NEPHROLOGIE, 21(8), 2000, pp. 425-430
Citation: R. Montagnac et al., Advantage of an end-stage renal failure registry. Experience of Champagne-Ardenne, NEPHROLOGIE, 21(8), 2000, pp. 431-435
Citation: P. Zaoui, Kidneys and lipids: Recent findings, progression of renal disease and effects of kidney replacement therapies - Grenoble, April 16-17, 1999 - Preface, NEPHROLOGIE, 21(7), 2000, pp. 315-315
Citation: R. Boizel, Atherosclerosis and arteriosclerosis of small vessels in chronic renal insufficiency and after kidney transplantation - Role of lipids, NEPHROLOGIE, 21(7), 2000, pp. 329-332
Citation: B. Moulin, Lipid abnormalities in renal insufficiency: Implications for progression of kidney failure and cardiovasclar risk, NEPHROLOGIE, 21(7), 2000, pp. 339-341